Divalproex Sodium Tablet, Delayed Release
Product Images NDC 71335-2862

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Divalproex Sodium (NDC 71335-2862). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (674e58bd F580 4805 A7e2 Febcaa37bca5 01)

Chemical structure of Divalproex Sodium is shown as a polymeric complex with sodium ions, depicting valproate units linked with sodium carboxylate groups. The image highlights the molecular arrangement with carbon, hydrogen, oxygen, and sodium atoms in the structure.*

FDA Label Image

Image (674e58bd F580 4805 A7e2 Febcaa37bca5 02)

A bar graph comparing percentages for Divalproex Sodium (DVPX) and placebo (PBO) groups across two studies. Study 1 results show 26% for PBO and 60% for DVPX, while Study 2 results show 29% for PBO and 58% for DVPX. The vertical axis represents percentage values up to 70%.*

FDA Label Image

Image (674e58bd F580 4805 A7e2 Febcaa37bca5 03)

A cumulative response curve chart comparing the percentage reduction in CPS rate between Divalproex Sodium and Placebo across patients. The y-axis shows percentage change ranging from -100% to 100%, indicating worsening or improvement, while the x-axis displays the percentage of patients from 100% to 0%.*

FDA Label Image

Image (674e58bd F580 4805 A7e2 Febcaa37bca5 04)

A line chart showing the percentage reduction in CPS rate versus the percentage of patients for high dose and low dose groups. The vertical axis ranges from -100% to 100% indicating worsening or improvement, and the horizontal axis shows the cumulative percentage of patients from 0 to 100%. The chart compares effect on CPS rate for high dose (solid line) and low dose (dashed line) treatments.*

FDA Label Image

Image (674e58bd F580 4805 A7e2 Febcaa37bca5 05)

A bar chart comparing values labeled Placebo and Divalproex Sodium for two studies, Study 1 and Study 2. Each study has two bars showing differences in measured quantities for Placebo versus Divalproex Sodium.*

FDA Label Image

Image (674e58bd F580 4805 A7e2 Febcaa37bca5 1830 2)

FDA Label Image

Label (Lbl713352862)

Label for Divalproex Sodium Delayed Release Tablets, USP 250 mg, oral dosage form, packaged as 100 tablets. The label includes the NDC number 71335-2862-1 and indicates the product is relabeled by Bryant Ranch Prepack and manufactured by Unichem Laboratories Ltd. Storage instructions and QR codes for prescribing information and package insert are also visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.